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Abstract
Background: Especially children at risk for asthma are sensitive to the detrimental health effects of passive smoke
(PS) exposure, like respiratory complaints and allergic sensitisation. Therefore, effective prevention of PS exposure in
this group of vulnerable children is important. Based on previous studies, we hypothesized that an effective
intervention program to prevent PS exposure in children is possible by means of a motivational interviewing
tailored program with repeated contacts focussing on awareness, knowledge, beliefs (pros/cons), perceived barriers
and needs of parents, in combination with feedback about urine cotinine levels of the children. The aim of the
PREPASE study is to test the effectiveness of such an intervention program towards eliminating or reducing of PS
exposure in children at risk for asthma. This article describes the protocol of the PREPASE study.
Methods: The study is a one-year follow-up randomized controlled trial. Families with children (0–13 years of age)
having an asthma predisposition who experience PS exposure at home are randomized into an intervention group
receiving an intervention or a control group receiving care as usual. The intervention is given by trained research
assistants. The intervention starts one month after a baseline measurement and takes place once per month for an
hour during six home based counselling sessions. The primary outcome measure is the percentage of families
curtailing PS exposure in children (parental report verified with the urine cotinine concentrations of the children)
after 6 months. The secondary outcome measures include: household nicotine level, the child’s lung function,
airway inflammation and oxidative stress, presence of wheezing and questionnaires on respiratory symptoms, and
quality of life. A process evaluation is included. Most of the measurements take place every 3 months (baseline and
after 3, 6, 9 and 12 months of study).
Conclusion: The PREPASE study incorporates successful elements of previous interventions and may therefore be
very promising. If proven effective, the intervention will benefit the health of children at risk for asthma and may
also create opportunity to be tested in other population.
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Background
Despite current efforts to prevent passive smoking,
some people are still being exposed to passive smoke
(PS) involuntarily, especially children because they can-
not protect themselves. The World Health Organization
estimates that about 40% of children worldwide are
exposed to PS [1]. Currently, about 25% of the Dutch
population 15 years and older smoke [2]. Although we
have seen a major decrease in PS exposure in children,
children with (heavy) smoking parent(s) and children
from socially deprived families are more likely to be
exposed [3]. The harmful health effects of PS exposure
in children are enormous and include higher risks of
respiratory complaints, varying from airway infections
like bronchitis and pneumonia, allergic sensitization to
allergens and asthma, to even more serious events like
sudden infant dead syndrome and meningococcal septic
shock [4-7]. Furthermore, the effect of PS exposure on
the airways in children is modified by a positive family
history of asthma [8,9]. This underlines the importance
of effective strategies to prevent PS exposure in chil-
dren, particularly those with high risk of asthma. The
available literature clearly indicates that prevention of
PS exposure in children is difficult to achieve. Various
intervention strategies have been developed and tested,
but the results are mixed. A narrative review of the ef-
fectiveness of 36 trials found only 11 trials to be suc-
cessful in reducing PS exposure in children [10].
However, 23 of the 36 studies showed an overall reduc-
tion of PS exposure in children regardless of the group
allocation. A more recent review and meta-analysis of
18 trials found a positive intervention effect in 13 stud-
ies, with 4 showing a statistically significant advantage
for the intervention group [11]. Overall, the trial
designs were diverse, ranging from a clinical setting to
home-based, different trial durations, and counselling
modalities extending from personal behavioural to web-
based counselling. Yet, certain elements of intervention
studies appeared to be effective. Positive effects on
stopping PS exposure in children have been described
for behavioural counselling methods, such as motivational
interviewing (MI) [12]. MI is a client-centred, directive
method for enhancing intrinsic motivation to change by
exploring and resolving ambivalence [13]. In a scientific
setting, MI outperformed traditional advice in the treat-
ment of a broad range of behavioural problems and
diseases [14]. But behavioural counselling alone is probably
not enough for an effective, long-lasting intervention effect
to prevent PS exposure in children [15,16]. The addition of
repeated feedback on children’s urinary cotinine levels to
behaviour-changing strategies seemed to reduce the urine
cotinine concentrations in children and the proportion of
parents quitting smoking [17,18]. Also, brief interventions,
even when used with additional information brochures,
were not effective [19,20]; indicating that more than one
counselling session is needed to increase the effectiveness
of interventions towards stopping of PS exposure in chil-
dren. The development of an effective intervention pro-
gram to prevent PS exposure in children is challenging.
However, an intervention program that incorporates all
successful elements of earlier studies may have high chance
of being effective.
Hypothesis
The hypothesis of the PREPASE study (PREvention of
PAssive Smoke Exposure) is that an effective interven-
tion towards eliminating or reducing PS exposure in
children with a high risk of asthma is possible by means
of a motivational interviewing tailored program with
repeated contacts focussing on awareness, knowledge,
beliefs (pro/cons), perceived barriers and needs of
parents, in combination with feedback about urine
cotinine levels of the children.
Aim
The aim of the PREPASE study is to test the effectiveness
of an intervention program towards eliminating or redu-
cing PS exposure in children with high risk of asthma.
Our primary research question is
What is the effectiveness of a motivational interviewing
tailored program including urinary cotinine feedback to-
wards eliminating or reducing PS exposure in children
with a high risk of asthma (measured 6 months after the
start of the intervention)?
In this study, children with a high risk of asthma are
defined as children with a positive family history of
asthma in the first degree (father/mother/sibling). The
children do not have an asthma diagnosis themselves.
The intervention is successful if the percentage of
parents reporting to eliminate or reduce PS exposure in
their children (also checked with the children’s urine
cotinine concentration) 6 months after the start of the
intervention is significantly higher in the intervention
group than in the control group.
Our secondary research questions are
1. Does eliminating or reducing PS exposure in children
persist after the intervention program (measured at 9
and 12 months of follow-up)?
2. What is the effect of the intervention on parents’
active smoking? Will the intervention also lead to
smoking cessation?
3. What is the influence of PS exposure in children
with high risk of asthma on their lung function,
inflammatory markers in exhaled breath and
respiratory complaints?
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The aim of this article is to describe the PREPASE
study design, which could benefit others who are plan-
ning comparable intervention programs.
Methods/design
Study design
The study is a one year randomized controlled interven-
tion study comparing “care as usual” to an intervention
program towards eliminating or reducing PS exposure in
children with high risk of asthma delivered by trained
research assistants (RA). The study is conducted in
South Limburg, Netherlands at the Maastricht Univer-
sity Medical Centre (MUMC+).
Eligibility
Inclusion criteria to participate in the PREPASE study
are families where the youngest child is 0–13 years old
and he/she does not has an asthma diagnosis but has a
high risk of asthma (father/mother/sibling has asthma)
and is exposed to PS at home by at least one parent. Ex-
clusion criteria are: children who are actively smoking
themselves, parents and/or children with mental retard-
ation, children with lung diseases such as asthma, or
cystic fibrosis, and, families already receiving profes-
sional support for smoking cessation.
Recruitment
Self-referral strategies
First, a random sample of 6987 children aged 0–13 years
are selected from the community registries of the civil
affairs department of three cities (Heerlen, Maastricht
and Sittard-Geleen) in South Limburg. Second, 3013
children aged 0–13 years are selected form the Registra-
tion Network of Family Practices (RNH Dutch acronym)
[21]. All families receive an invitation letter to partici-
pate in the study, including an informed consent form,
two questionnaires (A and B) and a stamped addressed
envelope. Parents who want to participate are instructed
to complete questionnaire A for their youngest child and
return it to the research group with the informed con-
sent form. Parents who do not want to participate are
asked whether they are willing to complete question-
naire B for the purpose of a non-response analysis.
Parents are informed that participation is voluntary but
in case of no response, a single reminder letter is sent
after two weeks. Questionnaire A includes 91 items (see
Additional file 1) and is composed of three parts. The
first part consists of general questions on family
characteristics: gender and birth date of the child, rela-
tionship of the caregiver(s) to the child, birth date of the
caregiver(s), the number and birth date of siblings, edu-
cation level and working situation of the caregiver(s),
and ethnicity. The second part of the questionnaire
inquire about the child’s general and respiratory health
using a Dutch version of the ISAAC questionnaire
[22,23], and questions concerning physician diagnosed
respiratory infections in the past 12 months, vitamin
use, gestational age at birth, birth weight, complication
(s) during pregnancy, breast feeding, smoking during
pregnancy, diagnosis of syndrome(s) or congenital dis-
ease(s), day-care attendance, and the presence of phys-
ician diagnosed asthma, eczema or hay fever in the
biological parents and or siblings of the child. The third
part of the questionnaire consists of questions about
parental smoking behaviour and passive smoke exposure
towards the child. Smoking behaviour of the parents is
measured with a standard questionnaire [24]. Questions
about PS exposure in children are derived from earlier
studies [25,26] and expert opinions from researches in
the field, and included sources of PS exposure at home
and elsewhere. Questionnaire B consists of 11 items, in-
cluding gender and birth date of the child, relationship
of the caregiver(s) to the child, wheezing and respiratory
complaints in the past 12 months, physician diagnosed
asthma, PS exposure during pregnancy and currently,
and reasons for not participating in the study.
The third source of recruitment is via cohorts from
the MIKADO study [27] and the ADEM study [28] from
the department of child pulmonology MUMC+. Families
that do not meet the eligibility criteria for the MIKADO
study or who complete the ADEM study, and in both
cases, give agreement to be contacted for other studies
receive a letter from the MIKADO or ADEM team
asking them if they would like to be contacted to receive
information from the PREPASE study.
The fourth self-referral recruitment strategy is done
through primary schools in South Limburg. Parents of
32.000 children aged 6–12 years receive an information let-
ter to participate in an electronic survey (see Additional
file 1) study regarding respiratory complaints in children
in South Limburg. All letters include the web address of
the survey and a unique password to log into the web-
site. The electronic questionnaire is similar to question-
naire A, but with minor adjustments. From the ISAAC
only questions regarding wheezing and asthma are used.
Moreover, questions regarding parental smoking behaviour
are limited to PS exposure towards the child. Schools are
encouraged to motivate participation. After two weeks, all
parents receive a reminder letter through the primary
schools of their children. The fifth source of recruitment is
through advertisements in local newspapers.
Physician based strategies
Since our target group is likely to consist of a more
disadvantaged or vulnerable population, physicians
working in the paediatric field (general practitioners,
paediatricians and doctors of child and youth health care)
are asked to select eligible families to participate from
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their patient registries or actively during consultations
[29]. These families receive information from the study
through their physicians and are asked by their
physicians if they grant permission to be contacted by a
PREPASE study team member for more information.
Furthermore, registries of all children in South Limburg
at the Regional Public Health Service (GGD Dutch acro-
nym) are checked for eligibility (child 0–13 years of age
with high risk of asthma and PS exposure at home). Eli-
gible families receive an invitation letter from their phys-
ician to participate in the study.
Except for the recruitment through the community
registries and RNH, we cannot control if a family is
approached more than once. For the analysis, recruit-
ment source is taken into account. Regardless of the re-
cruitment method, all parents are informed that the
MUMC+ is testing the effectiveness of a program to pre-
vent PS exposure in children with high risk of asthma,
that the program occurs in the home setting and
includes non-invasive measurements of the lung func-
tion of the children and that all families will receive a fi-
nancial reward after complete participation. Parents can
give permission to be contacted by a member of the re-
search group if they want more information or are
interested to participate in the study.
Randomisation
Eligible families are contacted by phone to ensure
eligibility and willingness to participate in the study.
Eligible families, after giving written informed con-
sent, are randomized into one of the two groups, the
intervention group or control group, with an alloca-
tion ratio of 1 (see Figure 1). A database logistic sys-
tem is made for the study by MEMIC (Centre for
data and information management, MUMC+), and
includes a randomization system. Families are pre-
stratified according to the age of the child, <6 years
and ≥6 years, to prevent chance imbalances between
the intervention and the control group with respect
to age and age-related variables, such as lung func-
tion and possible parental attitude towards passive
smoking (parents with younger children may evaluate
PS exposure differently from parents with older chil-
dren). Separate randomization lists are generated for
each stratum to ensure treatment group assignments
are balanced within each stratum.
Blinding of participants or members of the research
team for this study is not possible. However, prior to
randomization the participants receive limited informa-
tion on the intervention program. Participants are
informed that the study aims at testing a program to
help parents prevent PS exposure in their children and
to study the relationship between PS exposure and re-
spiratory complaints in children.
After randomization, parents receive more information
about their group allocation. All visits are planned for
the entire study period, and a confirmation letter is sent
to the participants including information and materials
with instructions for the urine sampling and lung func-
tion measurements in children.
Intervention program towards eliminating or reducing of
PS exposure in children
In MI, the parents’ choice, personal responsibility for
change, and enhancement of self-efficacy are emphasized
[13]. The communication method (using open-ended
questions, providing affirmation, listening reflectively and
providing summaries) elicits the parents own inherent
arguments for change (change talk), and increases their
awareness of the discrepancy between their current behav-
iour and what would happen if they decide to eliminate or
reduce PS exposure in their children. Counselling is fo-
cused on building motivation within parents, empathy and
giving confidence to parents. Possible ambivalence with
the decision to eliminate or reduce PS exposure in their
children (and to stop active smoking) is discussed. Goal
setting is used to help parents identify steps that they want
to take to prevent PS exposure in their homes. Possible
barriers experienced by the parent(s) are also discussed. As
an awareness raiser, parents receive feedback from the
children’s urine cotinine concentrations. The intervention
Figure 1 Flowchart of the PREPASE study. BM = baseline
measurement. M = Measurement. The first session starts 1 month
after the BM and take place once per month during 6 months. The
measurements take place every 3 months after the BM.
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program is based on the principles of the reasoned action
model for the prediction and change of behaviour [30].
This model suggests that behaviour is best predicted by a
person’s intention to perform certain behaviour. The
intention to perform behaviour is predicted by a combin-
ation of considerations which take on different weights.
These considerations are formed by a person’s: 1) beliefs
towards the behaviour which determines their attitude to-
wards the behaviour, 2) normative beliefs concerning the
behaviour which produce a perceived norm concerning the
behaviour, in other words, the perceived social pressure to
(not) engage in a certain behaviour, and 3) control beliefs
which are the person’s perceived personal and environ-
mental factors that can facilitate or inhibit performance of
the behaviour. Moreover, background factors such as past
behaviour, education, and abilities also influence a person’s
beliefs and resulting behaviour. These behavioural
determinants are measured and considered during the
sessions of the PREPASE intervention program. The inter-
vention is given by two trained RAs and consists of 6 coun-
selling session at home during 6 months, each lasting
about 60 minutes (see Figure 1). Each family is coupled
with one of the RAs. The RAs are prepared by receiving a
one day training “Growing up Smoke Free (Training
rookvrij opgroeien)” given by an expert from STIVORO
(Dutch expert centre on tobacco control). The training
includes general information regarding smoke addiction,
the health effects and measures to prevent PS exposure in
children, and basic training on motivational interviewing.
Further coaching is given on a regular basis.
In the beginning, parents are told that our primary
focus is on preventing PS exposure in children, and that
quitting active smoking is not required. The intervention
is tailored to whether parents are interested in reducing
and/or eliminating PS exposure in their children, or if
they are interested in quitting active smoking as well. If
both parents of a child smoke, they are counselled to-
gether to enable a long-lasting intervention effect. If only
one parent smokes, the other parent is still requested to
be present during the session. The non-smoker parent
may motivate the smoking parent or and reinforce his or
her goals to prevent or eliminate PS exposure in their
child. If parents permit, the counselling sessions are
recorded on audio. The purpose of the recordings is to
randomly examine the treatment fidelity. Although the
intervention is tailored, a counselling protocol is
developed to serve as a guideline for the counselling
sessions. The following subjects are discussed:
Session 1 - awareness of passive smoking in children
1. After an introduction by the RA details of parental
smoking behaviour are assessed: number of cigarette
smoked per day, possible quitting attempts in the past
and the successes in these attempts, smoking behaviour
inside the house and in the presence of their children.
Afterwards, the parents are informed about PS
exposure in children: the hazardous chemicals found
in tobacco smoke, and the forms of PS exposure
(second-hand smoke and third-hand smoke [31]).
2. Knowledge about the health effects of PS exposure in
children is assessed and if parents want more
information, this is provided.
3. Motivation and self-efficacy to prevent PS exposure
in children are assessed with the importance and
confidence ruler developed by Rollnick [32].
4. Parental readiness to prevent PS exposure in children
is assessed. In case parents are ready to start
preventing PS exposure in their children, the
following subjects are discussed: measures to prevent
PS exposure in children, parents’ personal goals, and,
possible barriers and solutions. They are encouraged
to make a ‘quit plan’ (see Table 1), that includes a
quit date and their specific measures and goals. In
case parents are not ready to change their behaviour,
ambivalence is assessed and parents are encouraged
to think about the cons and pros of preventing PS
exposure in children for the following session.
5. The RA gives a summary of the session.
Session 2 - preparation, planning quit-date and plan
1. The RA gives a short summary of session 1.
2. For parents who did not make a plan to quit PS
exposure in their child: motivation, self-efficacy and
readiness to prevent PS exposure in children are
reassessed as described in session 1.3 and 1.4.
Possible ambivalence, barriers and solutions are
discussed. In case parents are ready, they are
motivated to make a ‘quit plan’. Emphasis is put on
the positive influence which the parents can have on
the health of their children.
3. For parents who made a ‘quit plan’ during session 1
the ‘quit plan’ is evaluated. Self-efficacy is assessed.
Difficulties parents may have encountered are also
discussed. Parents are encouraged to reward
themselves for their efforts. Parents may reformulate
their specific goals.
4. Feedback about urine cotinine is given.
5. The RA gives a summary of the session.
Session 3 - evaluation of the ‘quit plan’
1. The RA gives a short summary of what has been
discussed previously (including possible ambivalence,
barriers and solutions) and (if applicable) the specific
goals parents have made to prevent PS exposure in
their children.
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2. The ‘quit plan’ is evaluated as described under
session 2.3. Furthermore, parents have the
opportunity to reformulate their specific goals or add
new goals to their ‘quit plan’.
3. For parents who did not make a plan to eliminate
or reduce PS exposure in their child: motivation,
self-efficacy and readiness to prevent PS exposure
in children are reassessed as described in session
1.3 and 1.4.
4. The RA gives a summary of the session.
Session 4 & 5 - evaluation and focus on difficult situations
1. The RA gives a short summary of what has been
discussed previously (session 3.1).
2. The ‘quit plan’ is evaluated as described under
session 2.3.
3. Possible difficulties and new barriers are
discussed. Parental behaviour towards difficult
situations (social influences) such as visiting
friends who are accustomed to smoking in the
house, are further discussed. Moreover, measures
to prevent PS exposure of their children
elsewhere, for example when visiting
grandparents, are discussed. Parents are motivated
to maintain their accomplishments in eliminating
or reducing PS exposure in their children.
Enhancement of self-efficacy is emphasized.
Parents may reformulate their specific goals.
4. Feedback about urine cotinine is given during session 4.
5. The RA gives a summary of the session.
Session 6 - making long-term goals
1. The RA gives a short summary of what has been
discussed previously
2. The ‘quit plan’ is evaluated as described under
session 2.3.
3. Possible difficulties and (new) barriers are discussed
as described under session 4/5.3.
4. Specific goals for the future (in order to reach a
long-lasting intervention effect) are formulated.
5. Feedback about urine cotinine is given.
6. The RA gives a summary of the session and
acknowledges the parents for their participation and
compliments them for their efforts to prevent PS
exposure in their children.
The RAs receive an extensive protocol with examples
of different scenarios and how to deal with possible re-
sistance during the sessions. Furthermore, to assist the
RA during the visits, a summary of each session is given
in the form of a schematic presentation; an example of
session 1 is given in Figure 2.
Prior to the RCT, the first two sessions of the inter-
vention program were tested and evaluated in 11 parents
who reported smoking at home in the presence of their
children. Our objective was to test the feasibility of the
Table 1 An overview of a ‘quit plan’
Quit plan
My goals are: •. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .‥
• . . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .‥
My most important reason(s) for preventing passive smoke exposure
in my child is (are):
1) . . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .
2) . . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .
To accomplish my goal(s), I will take the following measures:
Specific action: Date:
1) . . .. . .. . .. . .. . .. . .. . .. . . . . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .
2) . . .. . .. . .. . .. . .. . .. . .. . . . . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .
These are the following difficulties I may encounter and how I plan
to solve them:
Difficulties: Solution:
1) . . .. . .. . .. . .. . .. . .. . .. . . . . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .
2) . . .. . .. . .. . .. . .. . .. . .. . . . . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .
Other person(s) that could help me achieve my goals:
Person(s): How?:
1) . . .. . .. . .. . .. . .. . .. . .. . . 1) . . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .
2) . . .. . .. . .. . .. . .. . .. . .. . . 2) . . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .
I will use the following results to ensure me that I am achieving
my goals:
• . . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .‥
• . . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .‥
A copy of the ‘quit plan’ is included in the information booklet.
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intervention program and to gain more knowledge on
the attitudes and beliefs of parents towards PS exposure
in children and the barriers parents may encounter
when eliminating or reducing PS exposure in their chil-
dren. All parents completed the counselling sessions. Be-
fore the intervention, 6 parents (54.5%) fully agreed that
eliminating PS exposure in their children is of great im-
portance, 2 (33.3%) reported that it would be easy to ac-
complish. After two counselling sessions, 10 parents
(90.9%) were planning to eliminate PS exposure in their
children. The pilot study demonstrated good feasibility
of the new intervention program. All parents were happy
with the intervention style, duration, and found it rele-
vant for parents who are smoking in the presence of
their children.
Control group
During the entire study, the control group receives only
measurements according to the same protocol and time
plan as for the intervention group. The parents are
informed about the results of the measurements after
completion of the study. In case parents request more
information on passive smoke exposure in children, they
are encouraged to contact their general practitioner.
Introduce self
Assess current smoking 
behaviour*
Assess knowledge regarding 
passive smoke exposure
in children
Assess motivation and self-
efficacy with ruler
Assess readiness to change
Ask: “May I ask you what 
you already know about 
passive smoke exposure
in children?”
Ask: “Can I give you (more) 
information?”
Ask: “To what extend are 
you willing to do something 
about passive smoke 
exposure to your child?”
Ask: “What would it take for 
you to choose a higher 
number?”
Ask: “Why did you not 
choose a lower number?”
Ready:
1. Discuss measures that 
can be taken
2. Encourage parent to set 
goals
3. Discuss possible barriers 
and solutions




Figure 2 Schematic presentation of session 1. *The assessment of current smoking behaviour is done during every session.
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Outcomes
An overview of the measurements is provided in Table 2.
All measurements are home-based and all questionnaires
are completed by the parents.
Primary outcome measures
Eliminating or reducing PS exposure in children
PS exposure is measured with a standard questionnaire
(at baseline and at 3, 6, 9, and 12 months after the base-
line measurement) and is checked by urine cotinine
concentrations of the children. In the PREPASE study,
the percentage of parents eliminating or reducing PS ex-
posure in children at home at 6 months (directly after
the intervention program) is compared between the
intervention and the control group. Eliminating or redu-
cing PS exposure in children can be achieved ideally by
parents stopping active smoking or less ideally by
parents smoking outside the house.
PS exposure in children is measured with the following
questions: “Do you smoke in the presence of your
child?” (yes/no) If yes, “Where do you smoke in the
presence of your child and does this occur always, regu-
larly, sometimes or never?” (Parents are asked to provide
an answer for the following locations: living room, own
bedroom, child’s bedroom, kitchen, under the hood, hall,
dining table/room, attic, rest/bathroom, balcony, garden,
car, other) “On average, how many tobacco products do
you smoke per day in the house while your child is
present at the moment?” (xx cigarettes/cigars/pipe per
day) “On average, how many tobacco products do you
smoke per day outdoors while your child is present at
the moment?” (xx cigarettes/cigars/pipe per day). Further-
more, parental report is verified by the child’s urine cotinine
concentration.
Urine cotinine of the children
Cotinine is the major metabolite of nicotine and can
be detected in several bodily fluids, such as blood
serum, saliva and urine [33]. Urine samples are collected
(at baseline and after 3, 6, 9, and 12 months after the base-
line measurement) and analysed for cotinine using the gas
chromatography–mass spectrometry technique, Thermo
Scientific DSQIII (Axel Semrau GmbH & Co. KG,
Sprockhövel, Germany). Samples from children who have
not yet been trained to go to the toilet are collected by pla-
cing a highly absorbent cotton wool in the diapers. Samples
from toilet trained children are collected with a standard
urine collection cup. Early-morning urine samples are
collected on the day of the measurements by the RA or
primary researcher. The urine samples are analysed at
Medical Laboratory Humicon, B.V., Maastricht, the
Netherlands. The laboratory receives the urine samples on
the same day and stores them at 2-8° Celsius and analyses
them within 1–2 weeks. The samples are provided with a
numerical ID, the child’s birth year, date and time of collec-




Parents active smoking behaviour is measured (at base-
line and at 3, 6, 9, and 12 months after the baseline
measurement) with a standard questionnaire [24] and
questions related to PS exposure in children (in addition
to the questions above, parental attitudes, normative and
self-efficacy beliefs concerning the prevention of PS
exposure in children are also assessed) (see Additional
file 1). When applicable, both parents are asked to
complete the questionnaire.
Table 2 Overview of the outcome measurements
Time (months) 0 3 6 9 12
Outcome measures
Measurements:
Urine cotinine ● ● ● ● ●
Household nicotine level ● ●
EBC ● ●
Wheezometer ● ●
Long function ● ● ● ● ●
Questionnaires:
Parental smoking behaviour [24], PS exposure to the child Beliefs about PS exposure in children ● ● ● ● ●
Respiratory symptoms and infections (based on questions developed by the PREPASE team and
the respiratory symptoms questionnaire [37]
● ● ● ● ●
ISAAC [23] ● ●
Quality of life (FSII) [38] ● ● ● ● ●
Process evaluation ●
The measurements take place in both groups of the RCT, all measurements are home based. The process evaluation questionnaire is completed only in the
intervention group. Questionnaires are completed by the parents. PS = passive smoke.
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Household nicotine measurements
Household nicotine levels are measured (at baseline and
12 months after baseline) by placing a passive sampling
diffusion monitor in the living room area [34]. The
monitors are placed in the homes and removed one week
later. The household nicotine concentrations levels are
analysed by means of gas chromatography at the University
of California at Berkeley School of Public Health.
Airway inflammation and oxidative stress
Non-invasive parameters of airway inflammation and oxi-
dative stress are assessed (at baseline and 6 months after
baseline) with the handheld exhaled breath condensate
(EBC) sampling device Ecoscreen, (CareFusion, Germany).
A nose-clip is used and children are instructed to breathe
tidally through a mouthpiece with a two-way non-
rebreathing valve during 10 minutes. Saliva contamination
is prevented by a saliva trap. Children are distracted by
watching a video or by playing on a portable gaming de-
vice. After 10 minutes the condensate is collected in 1.5 ml
Eppendorf tubes (original Eppendorf Protein LoBind
Tube). Tubes are filled with 100 μl of condensate,
depending on the amount of condensate acquired
during collection. Directly after, acidity (pH) of the
EBC is measured with pHenomenal pH-1000H (VWR
Int., Leuven, Belgium). A minimum of 150-200 μl of
EBC is needed for the pH measurement. The
Eppendorf tubes are frozen with dry-ice, directly after pH-
measurement and are stored at −80 °C. The condensate is
analysed for markers relevant for asthma and airway in-
flammation (IL-4, IL-5, IL-6, IL-8, IL-10, IL-12p70, IL-13
and TNF-.alpha;) [35] as described in earlier studies.
Wheezing
Possible presence of wheezing is measured (at baseline and
6 months after baseline) with a non-invasive handheld
instrument, WheezometerTM (KaramelSonix Ltd). The
Wheezometer is placed behind the manubrium while the
child is asked to breathe normally. Breath sounds from the
trachea are recorded during 30 seconds and in case wheez-
ing is present, it is presented as a wheeze rate (Tw/Ttot%).
Lung function: measuring airway resistance in children
≤5 years of age
In children aged 5 years and younger, measurements of
airway resistance are performed (at baseline and at 3, 6,
9, and 12 months after the baseline measurement) by
means of the MicroRint (Micro Medical, Rochester Ltd,
UK) [36]. Children are asked to sit in an upright position
and to breathe normally through a facemask. Their at-
tention is diverted by video clips to guarantee tidal
breathing as much as possible. Five airflow interruptions
are made on the peak flow of expiration, the median
MicroRint value together with the flow and pressure
curves are displayed. The median MicroRint value is used
for analysis. Afterwards, 300 microgram of salbutamol
(AiromirW, Teva Pharma NL, Haarlem, the Netherlands)
is inhaled through the AeroChamberW (Trudell Medical
International, Ontario, Canada). After 15 minutes,
MicroRint measurements are repeated to assess the re-
versibility to the salbutamol.
Lung function: dynamic spirometry in children 6–13 years
of age
In children aged 6–13 years, dynamic spirometry is
performed (at baseline and at 3, 6, 9, and 12 months after
the baseline measurement) by means of the Flowhandy
Zan 100USBW (nSpire Health GmbH, Germany). The
ZAN-100 pulmonary spirometer is attached to a laptop
making it possible to perform home-based measurements.
Standard spirometry references are created by entering
age, weight, length and sex of the child. Children are
instructed and motivated before and during measurement.
Younger children, below 7–8 years of age, are stimulated
to perform better by using motivational images. A max-
imum of 8 maximal expiratory flow volume (MEFV)
curves are performed, until three technically satisfactory
measurements are achieved (ATS/ETS criteria). Thereafter,
300 microgram of salbutamol (AiromirW, Teva Pharma
NL, Haarlem, the Netherlands) is inhaled. After 15 minutes,
MEFV curves are measured as described earlier to assess
the reversibility to salbutamol. The highest forced expira-
tory volume in one second (FEV1), forced vital capacity
(FVC), and maximal expiratory flow at 50% FVC (MEF50)
are used for analysis. The FEV1 is expressed as a percent-
age of the predicted value (gender, age, ethnicity, weight,
height, ambient temperature, humidity and barometric
pressure taken into account).
Questionnaires on respiratory symptoms and quality of life
The presence of respiratory symptoms is assessed with
the ISAAC questionnaire [22,23] (at baseline and 12
months after baseline) and a standard questionnaire [37]
(at baseline and at 3, 6, 9, and 12 months after the base-
line measurement). Furthermore, the quality of life (FSII)
[38] in the children is also measured (at baseline and at
3, 6, 9, and 12 months after the baseline measurement).
(See Additional file 1).
Process evaluation
Parents in the intervention group receive a questionnaire
developed by our project group at the end of the study
to evaluate their overall experience and the different
components of the intervention program: content, coun-
selling style, the RA, and the information booklet (see
Additional file 1). Furthermore, random audio samples
of the sessions are independently evaluated by two
trained raters using the behaviour change counselling
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index (BECCI) [39]. The BECCI measures the RAs com-
petence in behaviour change counselling. The counsel-
ling sessions are rated with the 11 5-point Likert-scale
items of the BECCI scale to generate an overall score.
Statistical methods
Sample size calculation
The sample size calculation is based on the primary out-
come measure, the percentage of families eliminating or
reducing PS exposure in the intervention group versus
the control group after 6 months. Assuming a 10% stop-
ping PS exposure rate (by elimination or reduction) in
the control group because of a ‘trial effect’, a clinically
relevant difference in stopping rate between intervention
and control group of 20% (stopping rate of 30% in the
intervention group), a two tailed test with an alpha of
0.05 for the primary outcome, and a power of 80%, a
total number of N=126 families is necessary, assum-
ing one child is included per included family. With
an anticipated 15% drop-out rate in the RCT, at least
148 families (74 per group) are necessary to test the
effectiveness of the intervention.
Statistical methods
The results of the questionnaires are converted into
frequencies and percentages for binary and polytomous
variables and averages for continuous variables. For de-
scriptive purposes, baseline summary statistics of
demographics and outcomes will be tabulated per
group. The effect of the intervention will be assessed
by comparing the intervention and control group with
respect to the percentage of stopping (by eliminating
or reducing) of PS exposure in children (parentally
reported and verified with the children’s urine cotinine
concentration) 6 months after the start of the inter-
vention. The secondary outcome measures will also be
analysed for differences between the intervention and
control group. Dichotomous outcomes (stopping PS
exposure [by elimination or reduction] in children
[yes/no]) will be analysed with mixed logistic regres-
sion of PS exposure stopping status on treatment
group, time and group by time interaction. The ana-
lysis will both evaluate the group difference at the pri-
mary time point, 6 months, and the group divergence
over time. The analysis is an intention-to-treat analysis
which includes all randomized families with at least one
measurement. Continuous outcomes will be similarly
analysed with mixed linear regression. Non-normality of
such outcomes will be handled by data transformation,
for example a logarithmic or square root transformation
in case of severe positive skewness. Given randomized
assignment, no confounding is expected except due to
dropout, which is accommodated by using baseline
variables as covariates and including all randomized
children into the outcome analyses (intention-to-treat
analysis) using the direct Likelihood approach of mixed
regression, which requires no imputation of missing out-
come values. The primary outcome eliminating or redu-
cing PS exposure will be tested two-tailed with an alpha
of 5%, but secondary outcomes with an alpha of 1% to
prevent type I errors due to multiple testing.
Ethics
The PREPASE study was reviewed and approved by the
Medical Ethics Committee MUMC+, and is registered at
the Dutch Trial Register (NTR2632). The study protocol
is reviewed by the funding organization: the Dutch Lung
Foundation (grant 3.4.08.047).
Discussion
This manuscript describes the design of the PREPASE
study, a RCT testing the effectiveness of an intervention
program to prevent PS exposure in children with a high
risk of asthma. The main strength of the PREPASE study
is that it incorporates successful elements of previous
interventions to prevent PS exposure in children into
one program. If proven effective, the intervention can
also be tested in other groups, such as children without
high risk of asthma. We believe that the strongest com-
ponent of our program is that parents receive
individualized counselling in the comfort of their own
homes. Furthermore, the MI approach offers parents the
room to make their own decisions. Emphasis is put on
empathy and positive reflections and reinforcements by
the RA. However, there are some possible limitations of
the study. Ideally, the best method to prevent all PS expos-
ure in children is if parents quit active smoking. We can
advise parents to quit smoking, but not force them. Parents
are free to choose to smoke for example only in a room
where the child does not enter or outside. The parents are
motivated to make goals that they believe they can adhere
to, not what they think we expect them to do.
Furthermore, the information in the invitation letter
concerning the aim of our study could also induce stop-
ping behaviour in the control group. But due to ethical
reasons we are obliged to provide all the participants some
information of the study. In addition, getting parents to
participate in this study can be very challenging. Currently,
there is much attention in the media about PS exposure
and its negative health effects. Parents might not want to
participate in the PREPASE study because of feelings of
shame or embarrassment. Consequently, this can lead to
the participation of only parents who are highly motivated
to prevent PS exposure in their children. However, if this is
the case, we do not expect this to limit the generalizability
of the study. If the intervention is successful and
implemented in for example general practices, the chances
are high that mostly motivated parents would seek help for
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stopping PS exposure in their children. Also, the preva-
lence of PS exposure is highest in socially deprived fam-
ilies. Selecting and communicating with such families can
also be challenging. To minimize drop-outs as much as
possible, all parents receive a reminder letter one month
before the measurement. Furthermore, all children receive
a small gift after each measurement, and the families re-
ceive a financial incentive after completion of the study.
Conclusion
Various programs have been tested and have shown
some effect to decrease PS exposure in children. How-
ever, there is still room for improvement. As children
with a high risk of asthma are at increased risk of
developing respiratory complaints such as wheezing and
asthma due to PS exposure, effective programs are
needed to prevent PS exposure in this group of children.
The PREPASE study aims at testing such an intervention
program that will not only have important beneficial
health effects for children with higher risk of asthma,
but is also of great importance for our society.
Additional file
Additional file 1: Supplement questionnaires specifically developed
for the PREPASE study.
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